Search
Search Results
##search.searchResults.foundPlural##
-
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2783PDF: 1018HTML: 360Preferred Reviewers: 207 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2546PDF: 872HTML: 2123 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1714PDF: 626HTML: 1515Figure 1: MRI demonstrating Aspergillus synovitis: 184Figure 2:MRI demonstrating Aspergillus synovitis: 189 -
WHAT ARE FUNGAL INFECTIONS?
4190PDF: 2384HTML: 27605de Pauw: 235 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1575PDF: 505HTML: 234 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2877PDF: 1099HTML: 3030 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4306PDF: 1373HTML: 2040 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
879PDF: 685HTML: 320 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7967PDF: 4138HTML: 7369 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7844PDF: 721HTML: 216 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3688PDF: 1237HTML: 3894Untitled: 213Untitled: 259 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2883PDF: 1360HTML: 3569Untitled: 192Untitled: 202Untitled: 177 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4791PDF: 1898HTML: 11050Fig 1: 223Fig 2: 184Fig 3: 301Fig 4: 188Fig 5: 180Fig 6: 175Fig 7: 189Fig 8: 183 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1725PDF: 1163HTML: 246 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3268PDF: 1095HTML: 438 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1602PDF: 798HTML: 1232Figure 1: 172Figure 2: 188Figure 3: 183 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2069PDF: 1047HTML: 15650COVER LETTER: 190 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3699PDF: 1444HTML: 182 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1547PDF: 882HTML: 980figures: 178table 1: 181table2: 180table3: 183







